Imagen de Portada

Helicobacter pylori ‐Associated Extranodal Marginal Zone Lymphoma of Mucosa‐Associated Tissue in Children: A Multicenter Case Series

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Pesah Melnik, Ilana Weintraub, Hussein Shamaly, Shlomi Cohen, Noa Greenberg‐Kushnir, Ginette Schiby, Batia Weiss
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Helicobacter
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Helicobacter pylori Eradication Is Associated With a Reduced Risk of Metachronous Gastric Neoplasia by Restoring Immune Function in the Gastric Mucosa
por: Min‐Jae Kim, et al.
Publicado: (2025)

The Gastric Microbiota Invade the Lamina Propria in Helicobacter pylori ‐Associated Gastritis and Precancer
por: Harriet J. Giddings, et al.
Publicado: (2025)

A Bidirectional Association Between Helicobacter pylori Infection and Hyperlipidemia: Clinical Evidence and Mechanistic Insights
por: Yan'an Zhou, et al.
Publicado: (2026)

Host Genetic Variants Associated With Helicobacter pylori Infection: A Meta‐Analysis Combined With Functional Annotation
por: Wen‐Jing Zhao, et al.
Publicado: (2025)

Optimizing Duration and Dosing Frequency of Vonoprazan–Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial
por: Lulong Tao, et al.
Publicado: (2025)

Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China
por: Xueyan Lin, et al.
Publicado: (2024)

Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial
por: Jae Yong Park, et al.
Publicado: (2026)

Helicobacter pylori infection and inflammasomes
por: Huiling Zheng, et al.
Publicado: (2024)

Efficacy and Safety of Levofloxacin‐ Versus Moxifloxacin‐Based Nitazoxanide Quadruple Therapy as Second‐Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial
por: Gasser El‐Azab, et al.
Publicado: (2026)

Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”
Publicado: (2026)

Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial
por: Tian‐Lian Yan, et al.
Publicado: (2025)

Comparison of Therapeutic Outcomes Between Concomitant Therapy and Tailored Therapy for Helicobacter pylori: A Multicenter, Prospective, and Randomized Study
por: Young Sin Cho, et al.
Publicado: (2025)

Factors Associated With Decision to Treat or Not to Treat Helicobacter pylori Infection in Children: Data From the EuroPedHp Registry
por: Thu Giang Le Thi, et al.
Publicado: (2024)

Efficacy and Safety of Keverprazan–Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial
por: Shanshan Wei, et al.
Publicado: (2026)

Global Prevalence of Helicobacter pylori Infection‐Associated Gastric Preneoplastic Lesions in Pediatric Patients: A Systematic Review and Meta‐Analysis
por: Mohammed Awadh Abdun, et al.
Publicado: (2025)

A Three‐Way Comparison of Nodular Lesions in H. pylori ‐Induced Gastritis, Non‐ Helicobacter pylori Helicobacter ( NHPH )‐Induced Gastritis, and NHPH ‐Induced MALT Lymphoma Reveals Their Distinct Endoscopic Predictors: Distribution for Bacterial Etiology and Morphology for Malignancy
por: Yuki Kitadai, et al.
Publicado: (2025)

Candidate Antigens and the Development of Helicobacter pylori Vaccines
por: Zhanhua Zhang, et al.
Publicado: (2024)

Helicobacter pylori Infection in Children: To Eradicate or Not to Eradicate?
por: Marco Manfredi, et al.
Publicado: (2024)

Combatting Helicobacter pylori: A Focus on Nanomaterials
por: Xuanping Wang, et al.
Publicado: (2024)

Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis
por: Yuheng Zhang, et al.
Publicado: (2025)

Tracking the Helicobacter pylori Epidemic in Adults and Children in China
por: Zixing Wang, et al.
Publicado: (2024)

Helicobacter pylori Pathogenic Factors and Their Interactions With the Gastric Microbiome
por: Camilia Metadea Aji Savitri, et al.
Publicado: (2025)

Research progress in photodynamic therapy for Helicobacter pylori infection
por: Qian Luo, et al.
Publicado: (2024)

Efficacy of Tetracycline Three Times Daily was Comparable to That of Four Times Daily for Helicobacter pylori Rescue Treatment: A Multicenter, Noninferiority, Randomized Controlled Trial
por: Zhongxue Han, et al.
Publicado: (2024)

Comparison of Cefuroxime‐Based Dual Therapy With Quadruple Therapy in Helicobacter pylori‐Infected Treatment‐Naive Patients: A Prospective, Multicenter, Randomized Controlled Trial
por: Ji‐Yan Li, et al.
Publicado: (2025)

Roles of Gastric Non‐Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review
por: Mitsushige Sugimoto, et al.
Publicado: (2025)

Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship
por: Jen‐Yu Hsu, et al.
Publicado: (2025)

Fourteen‐Day Tegoprazan–Amoxicillin Dual Therapy as the First‐Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial
por: Qingzhou Kong, et al.
Publicado: (2024)

Concentration‐dependent effect of amoxicillin against clinical strains of Helicobacter pylori
por: Z. Kaouah, et al.
Publicado: (2024)

EUROHELICAN —Accelerating Gastric Cancer Reduction Through Helicobacter pylori Eradication
por: Bojan Tepeš, et al.
Publicado: (2026)

Exosome‐Based Detection of Helicobacter pylori Infection and Clarithromycin Resistance in Children
por: Minghui Song, et al.
Publicado: (2026)

Oral immunotherapy for Helicobacter pylori: Can it be trusted? A systematic review
por: Mohammad Hossein Peypar, et al.
Publicado: (2024)

Treatment failure is a key factor in the development of Helicobacter pylori resistance
por: Jinliang Xie, et al.
Publicado: (2024)

Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review
por: Xiaoqi Wu, et al.
Publicado: (2024)

First‐Line Therapy for Helicobacter pylori in Slovenia: Data From 2013 to 2023 of the European Registry on H. pylori Management
por: Bojan Tepes, et al.
Publicado: (2025)

Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection
por: Shihang Zhou, et al.
Publicado: (2024)

Lipidome Characterization Reveals Alterations of Fatty Acid Metabolism in Helicobacter pylori Infection
por: Hyder Alikhan, et al.
Publicado: (2025)

Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article
por: Changmin Mi, et al.
Publicado: (2024)

Helicobacter pylori Management in Africa: A Survey of Diagnostic, Treatment, and Related Resources
por: Setshedi Mashiko, et al.
Publicado: (2024)

Helicobacter pylori Eradication in Older Individuals: A Systematic Review and Meta‐Analysis
por: Sun Jae Moon, et al.
Publicado: (2025)